Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7899 USD | +4.89% | +11.58% | -83.90% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 15.58M | Capitalization | 2.78M |
---|---|---|---|---|---|
Net income 2024 * | -9M | Net income 2025 * | -9M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.18 x |
P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-0.63
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.26% |
Latest transcript on Quoin Pharmaceuticals, Ltd.
1 day | +4.89% | ||
1 week | +11.58% | ||
Current month | +11.58% | ||
1 month | -2.49% | ||
3 months | -76.35% | ||
6 months | -82.33% | ||
Current year | -83.90% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Myers
CEO | Chief Executive Officer | 62 | 18-03-04 |
Denise Carter
FOU | Founder | 55 | 18-03-04 |
Gordon Dunn
DFI | Director of Finance/CFO | 60 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Sember
BRD | Director/Board Member | - | 21-10-27 |
Dennis Langer
BRD | Director/Board Member | 73 | 21-10-27 |
Joseph Cooper
BRD | Director/Board Member | 66 | 21-10-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.7899 | +4.89% | 26,136 |
24-05-07 | 0.7531 | +1.09% | 38,468 |
24-05-06 | 0.745 | -4.03% | 33,812 |
24-05-03 | 0.7763 | +6.34% | 92,858 |
24-05-02 | 0.73 | +2.79% | 54,536 |
Delayed Quote Nasdaq, May 08, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.90% | 2.78M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- QNRX Stock